Quick Answer
Syra Health Corp reported Cash and Equivalents of $1.61 million for fiscal year 2025.
Syra Health Corp Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $1.61M | -32.6% |
| 2024 | $2.40M | -27.0% |
| 2023 | $3.28M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.98M | — | -14.3% |
| June 30, 2025 | $2.31M | — | -7.4% |
| March 31, 2025 | $2.49M | — | +4.0% |
| December 31, 2024 | $2.40M | — | +13200.4% |
| September 30, 2023 | $18.0K | — | +438.6% |
| December 31, 2022 | $3.3K | — | — |
- Syra Health Corp showed a decrease of -32.6% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2023–2025 period, Syra Health Corp’s cash and equivalents has declined by 50.8% (from $3.28 million to $1.61 million).
- The most recent figure is from Syra Health Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: